ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Neuralstem’s NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete … – GlobeNewswire (press release)

Continue reading

2018-06-04 Michael Zand NEWS

NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker … – GlobeNewswire (press release)

NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker …GlobeNewswire (press release)SEATTLE, June 04, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life scien… Continue reading

2018-06-04 Michael Zand NEWS

CRISPR approach could limit toxicity of CAR-T therapy in AML – Drug Target Review

Neuralstem’s NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete …
GlobeNewswire (press release)
Neuralstem Announces Publication of Data From First-In-Human Study of Human Neural Stem Cell Transplantation for Chronic Spinal Cord Injury -. – First cohort of four subjects with thoracic (T2-T12) ASIA-A grade spinal cord injury in the Phase I study …

and more »

Continue reading

2018-06-04 Michael Zand NEWS

A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking – STAT

A new cancer care dilemma: Patients want immunotherapy even when evidence is lackingSTATmmunotherapy is a source of great hope in cancer care. It has rescued some patients from the brink, while giving others a reason to believe that they, too, could be… Continue reading

2018-06-04 Michael Zand NEWS

Synthetic Biology Market to Rise at a Tremendous CAGR of 32.6% from 2013 to 2019 – Exclusive Reportage

Synthetic Biology Market to Rise at a Tremendous CAGR of 32.6% from 2013 to 2019Exclusive ReportageSynthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biolo… Continue reading

2018-06-04 Michael Zand NEWS

Crispr Stock Tumbles On FDA Clinical Hold, But European Study Remains On Track – Seeking Alpha

Seeking AlphaCrispr Stock Tumbles On FDA Clinical Hold, But European Study Remains On TrackSeeking AlphaCrispr Therapeutics received a clinical hold from the FDA for an IND on CTX-001 in treating patients with sickle cell disease. An FDA clinical hold … Continue reading

2018-06-04 Michael Zand NEWS

Stem Cell Therapy for Alzheimer’s – News-Medical.net


Drug Target Review

CRISPR approach could limit toxicity of CAR-T therapy in AML
Drug Target Review
A new approach may provide a new path towards treating acute myeloid leukaemia (AML) with CAR-T cells. To treat AML, investigators have to target a specific protein – CD33 – that’s also expressed on healthy cells, meaning the therapy cannot attack the …

Continue reading

2018-06-04 Michael Zand NEWS

Immunotherapy Drug Keytruda Halts ‘Untreatable’ Prostate Cancer In Some Men – Tech Times


News-Medical.net

Stem Cell Therapy for Alzheimer’s
News-Medical.net
Stem cell treatments target to replace the damaged cells with healthy stem cells which can grow on their own, hence, creating new healthy brain cells. Because the transplant is usually autologous (using patient’s own body cells) in nature, there are …
Taking Stem Cells to the BankPain News Network
Global and Chinese Autologous Stem Cell Market Report by Manufacturers, Opportunities, Challenges, Drivers, Growth …Business Investor
Market Analysis of Stem Cell Therapy for Diabetes and Related Conditions | Key Players Analysis and Forecast to 2021Exclusive Reportage
Clean Technology –Expert Consulting –Technical Progress
all 63 news articles »
Continue reading

2018-06-04 Michael Zand NEWS
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Tech Times

Immunotherapy Drug Keytruda Halts ‘Untreatable’ Prostate Cancer In Some Men
Tech Times
Earlier trials on using immunotherapy in prostate cancer have been unsuccessful. The latest trial, results of which were presented this weekend at the American Society of Clinical Oncology Meeting in Chicago, examined the genetics of tumors and found …
Immunotherapy could stop prostate cancer spreading, trial showsThe Guardian
Immunotherapy could treat prostate cancerThe European Scientist
‘Untreatable’ prostate cancer halted in some men by new immunotherapy drug, trial findsThe Independent
Forbes –BBC News –NHK WORLD
all 52 news articles »